BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 7560180)

  • 1. Nuclear pseudoinclusions in melanocytic naevi and melanomas.
    Rose DS
    J Clin Pathol; 1995 Jul; 48(7):676-7. PubMed ID: 7560180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of the value of Ag NOR staining in the identification of dysplastic and other borderline melanocytic naevi.
    MacKie RM; White SI; Seywright MM; Young H
    Br J Dermatol; 1989 Apr; 120(4):511-6. PubMed ID: 2471546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting.
    Gonzalez AP; Kumar D; Sánchez RL
    Am J Dermatopathol; 1994 Aug; 16(4):372-6. PubMed ID: 7526724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear and cytoplasmic features in the diagnosis of banal nevi, Spitz nevi, and melanoma.
    Valdebran M; Elbendary A; Chaitanya Arudra SK; Torres KM; Elattar I; Elston DM
    J Am Acad Dermatol; 2016 Nov; 75(5):1032-1037.e8. PubMed ID: 27542585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological demarcation of lateral borders: an unsupportable criterion for distinguishing malignant melanoma from Spitz naevus and compound naevus.
    Okun MR
    Histopathology; 1998 Aug; 33(2):158-62. PubMed ID: 9762549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear parameters in the superficial and deep portion of melanocytic lesions--a morphometrical investigation.
    Smolle J; Soyer HP; Juettner FM; Hoedl S; Kerl H
    Pathol Res Pract; 1988 Jun; 183(3):266-70. PubMed ID: 3420029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spitz naevi and malignant melanomas of childhood and adolescence.
    Peters MS; Goellner JR
    Histopathology; 1986 Dec; 10(12):1289-302. PubMed ID: 3817764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluating silver-stained nucleolar organizer regions (AgNORs) in problematic cutaneous melanocytic lesions: a study with quantitation and pattern analysis.
    Evans AT; Orrell JM; Grant A
    J Pathol; 1991 Sep; 165(1):61-7. PubMed ID: 1955937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative in situ evaluation of telomeres in fluorescence in situ hybridization-processed sections of cutaneous melanocytic lesions and correlation with telomerase activity.
    Miracco C; Margherita De Santi M; Schürfeld K; Santopietro R; Lalinga AV; Fimiani M; Biagioli M; Brogi M; De Felice C; Luzi P; Andreassi L
    Br J Dermatol; 2002 Mar; 146(3):399-408. PubMed ID: 11952539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic globules in pigmented spindle cell nevus.
    Wistuba I; Gonzalez S
    Am J Dermatopathol; 1990 Jun; 12(3):268-71. PubMed ID: 1693819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spitz naevi misdiagnosed histologically as melanoma: prevalence and clinical profile.
    Orchard DC; Dowling JP; Kelly JW
    Australas J Dermatol; 1997 Feb; 38(1):12-4. PubMed ID: 9046646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spitz melanocytic tumours - a review.
    Yeh I; Busam KJ
    Histopathology; 2022 Jan; 80(1):122-134. PubMed ID: 34958498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi.
    Langer K; Rappersberger K; Steiner A; Konrad K; Wolff K
    Arch Dermatol Res; 1990; 282(6):353-62. PubMed ID: 2260880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The approach to the patient with a difficult melanocytic lesion.
    Elder DE; Xu X
    Pathology; 2004 Oct; 36(5):428-34. PubMed ID: 15370112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dermoscopic classification of atypical melanocytic naevi (Clark naevi) is useful to discriminate benign from malignant melanocytic lesions.
    Blum A; Soyer HP; Garbe C; Kerl H; Rassner G; Hofmann-Wellenhof R
    Br J Dermatol; 2003 Dec; 149(6):1159-64. PubMed ID: 14674892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
    Fröhlich E; Mack AF; Garbe C; Klessen C
    Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface microscopy of naevi and melanomas--clues to melanoma.
    Nilles M; Boedeker RH; Schill WB
    Br J Dermatol; 1994 Mar; 130(3):349-55. PubMed ID: 8148277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.